Well-resourced team of sector experts with global experience
Team
Founder
Prashant Khemka, CFA
Prashant founded the Investment Adviser (together with the Investment Manager) in June 2017 after 17 years of leadership roles at Goldman Sachs. Prior to this he was the Chief Investment Officer (CIO) and Lead Portfolio Manager of the India Equity strategy at Goldman Sachs Asset Management (“GSAM”), from March 2007 to March 2017, and the Global Emerging Markets Equity strategy, from June 2013 to March 2017. As Lead Portfolio Manager, he managed all mutual funds and separate accounts under these two strategies.
Prashant began his professional investing career in 1998 at State Street Global Advisors in Boston as Senior Portfolio Officer of Enhanced International Equity in the Quant group. He moved to GSAM in 2000 as a research analyst for the US Growth Equity strategy and, by 2004, had become the Senior Portfolio Manager and Co-Chair of the Investment Committee. Prashant returned to Mumbai in 2006 to start GSAM’s India business and served as the CIO and CEO/Co-CEO of their domestic asset management company. In 2013, in addition to the India business, he was also made the CIO and Lead Portfolio Manager of GSAM’s Global Emerging Markets Equity strategy. He won several accolades as the CIO and Lead Portfolio Manager of GSAM’s India Equity strategy. He and his fund won several awards including an “AAA” rating from Citywire and an “Elite” rating from FundCalibre, among others.
Prashant graduated with honours from Mumbai University with a BE in Mechanical Engineering and earned an MBA in Finance from Vanderbilt University, where he received the Matt Wigginton Leadership Award for outstanding performance in Finance. He was awarded the CFA designation in 2001 and is a fellow of the Ananta Aspen Centre, India.
Investment Advisory Team
Manoj
Garg
Investment Director | 26 Years of Experience
Manoj joined White Oak in 2017 and is responsible for covering the pharma, specialty chemicals and auto sectors. Before joining White Oak, Manoj had a strong track record in equity research in healthcare and pharmaceuticals sector, working as a lead analyst at a number of leading brokerage houses in India. Most recently, he was with Merrill Lynch, where he was highly rated by external as well as internal clients. He received the highest votes for the multinational brokerage house in India during 2015-17. He was also ranked #1/#2 in the prestigious All Asia Institutional Survey 2015/2016 in the Healthcare category. He began his career in the pharmaceutical industry working with leading Indian pharmaceutical companies like Cipla and Ipca for 10 years. He graduated as a gold medallist from Nagpur University with an MBA degree in Finance.
ASHOKA INDIA EQUITY INVESTMENT TRUST PLC
Registered Office
6th Floor 125 London Wall, London, England, EC2Y 5AS
© Ashoka India Equity Investment Trust plc 2024. All rights reserved.
Privacy Policy | Terms & Conditions
Important information
You must read the following information before proceeding. It explains certain legal and regulatory restrictions that apply to the information contained in this Site. By accessing this Site, you agree to be bound by the terms and conditions below. If you do not agree to the terms and conditions below, do not access this Site.
The material on this Site is not an invitation or offer to buy or sell, or the solicitation or any offer to buy or sell, securities in any jurisdiction. This Site provides general information about Ashoka India Equity Investment Trust plc (the “Company”) only and does not constitute investment, tax, legal or other advice.
If you are unsure as to whether the investments described in this site are suitable for you, we strongly recommend that you seek professional advice from a financial adviser before making any investment or financial decisions. Any decision to make an investment should not be made on the basis of information contained in this Site and should only be made on the basis of the latest prospectus published by the Company and any subsequent regulatory announcements issued by the Company.
None of the information published or made available via this Site is intended to be published or made available in any jurisdiction where to do so would result in the breach of any applicable law or regulation in that jurisdiction. This Site is not directed at you if we are prohibited by any law of any jurisdiction from making the information on this Site available to you. You should satisfy yourself before accessing the Site that we would be allowed to advertise investments and investment services to you under the laws and regulations of your jurisdiction.
This Site is not for use by “US Persons”. A “US Person” is defined by US laws and regulations in force from time to time. If you are resident in the US, or as a corporation or other entity are organised under US law or administered by or operated for the benefit of a legal or natural US person, you should take professional advice to determine whether you are a US Person and you should not access this Site until you are sure that you are not a “US Person”.
You may download or print copies of the reports or information contained within this Site for your own private use only; all other copying, reproducing, transmitting, distributing or displaying of material on this Site (by any means and in whole or in part) is prohibited.
No warranty is made as to the accuracy or completeness of any information on this Site. Any price information or indications of past performance on this Site are for information purposes only, are subject to change without notice and can in no way be construed as a guarantee of future performance.
All investment is subject to risk. The value of the shares in the Company may go down as well as up. Past performance is no guarantee of future returns and there is no guarantee that the market price of the Company’s shares will fully reflect their underlying net asset value. There is also no guarantee that the Company’s investment objective or return objectives will be achieved.
This Site may contain or link to content which is generated by third parties. None of the Company, White Oak Capital Management Consultants LLP or Acorn Asset Management Ltd has approved this third party content and they will not be responsible or liable for that content or for the consequences of your use of it.
By accessing this site, you agree to be bound by these Terms & Conditions